ALISON EDELMAN
Oregon Health and Science University · Oregon Health and Sciences University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
16
all conditions, ClinicalTrials.gov
NIH grants tied to them
7
NIH RePORTER
Trial papers
52
PubMed author-name match
Trials
Studies that name ALISON EDELMAN as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:53 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06000423 · Tranexamic Acid to Reduce Contraceptive-related Bleeding Side EffectsOregon Health and Science University · completed · Bleeding, Contraceptive Device; Complications · principal investigator
- Early Ph1NCT05760144 · Endometrial Biopsy in Progestin Contraceptive UsersOregon Health and Science University · completed · Contraception · principal investigator
- Ph4NCT05674513 · Disparities in Emergency Contraceptive Metabolism Dictate EfficacyOregon Health and Science University · recruiting · Contraceptive Usage · principal investigator
- Ph2NCT03585712 · Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed PillHRA Pharma · completed · Contraception · principal investigator
- Ph4NCT02863445 · Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNGOregon Health and Science University · completed · Obesity · principal investigator
- Ph4NCT02859337 · Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPAOregon Health and Science University · completed · Obesity, Contraception · principal investigator
- Ph4NCT02577601 · Impact of Combined Hormonal Contraceptives on UPAOregon Health and Science University · completed · Contraception · principal investigator
- Ph4NCT02408692 · Emergency Contraception and Body Weight: Pilot StudyOregon Health and Science University · completed · Contraception, Body Weight · principal investigator
- Ph4NCT01170390 · Oral Contraceptives and Body Mass IndexOregon Health and Science University · completed · Body Weight, Contraceptive Usage · principal investigator
- N/ANCT01129245 · The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on OvulationOregon Health and Science University · completed · Ovulation, Luteal Development · principal investigator
- Ph4NCT00662454 · Oral Contraceptive Efficacy and Body WeightOregon Health and Science University · completed · Contraception, Body Weight · principal investigator
- N/ANCT00613366 · Misoprostol With Intrauterine Device InsertionOregon Health and Science University · completed · Contraception · principal investigator
- N/ANCT00613925 · Endometrial Biopsy Instrument Comparison StudyOregon Health and Science University · completed · Pain · principal investigator
- N/ANCT00613821 · Lidocaine and Pain Management in First Trimester AbortionsOregon Health and Science University · completed · Pain · principal investigator
- N/ANCT00614432 · Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated WomenUniversity of Hawaii · completed · Blood Loss · principal investigator
- N/ANCT00614406 · The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual CycleOregon Health and Science University · completed · Ovulation (Follicular Rupture Yes/no), Menstrual Cycles (Total Length, Bleeding Days), Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Pharmacogenomics of an ovulation modulator and the impact on delay of ovulationR01HD105866 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · fiscal years 2022 to 2026 · $312,903 awarded in 2026Grant number is on one of their registry trials
- NICHD:R&D:CENTRAL LABORATORY FOR A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION:NON-SEVERABLE75N94020D00 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · fiscal years 2021 to 2025 · $6,481 awarded in 2025Same name and institution; not confirmed by an ID
- Determining the impact of COVID-19 vaccination on the menstrual cycleR01HD089957 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · fiscal years 2017 to 2021 · $296,124 awarded in 2021Same name and institution; not confirmed by an ID
- CCTN - CLINICAL EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES 27520130000 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · fiscal years 2015 to 2020 · $228,654 awarded in 2020Same name and institution; not confirmed by an ID
- DO ORAL CONTRACEPTIVES CAUSE WEIGHT GAIN?P51RR000163 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · fiscal years 2008 to 2010 · $47,603 awarded in 2010Same name and institution; not confirmed by an ID
- Improving Contraceptive Effectiveness in Obese WomenR01HD061582 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · fiscal years 2009 to 2010 · $460,240 awarded in 2010Grant number is on one of their registry trials
- Contraceptive efficacy and body weight: Does obesity affect the risk of failure?R03HD053611 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · fiscal years 2006 to 2007 · $60,066 awarded in 2007Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:53 UTC. The ranking covers the 200 most relevant of 52 PubMed records, and a shared surname and initials can bring in a namesake. All 52 on PubMed
- In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.BMC Med · 2007130 citationsRCR 3.1
- Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial.Contraception · 2003106 citationsRCR 4.1
- Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women.Contraception · 201176 citationsRCR 3.8
- Paracervical block for pain control in first-trimester surgical abortion: a randomized controlled trial.Obstet Gynecol · 201244 citationsRCR 2.5
- Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial.Am J Obstet Gynecol · 200643 citationsRCR 1.9
- Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?Obstet Gynecol · 200640 citationsRCR 1.6
- Personalized contraceptive assistance and uptake of long-acting, reversible contraceptives by postpartum women: a randomized, controlled trial.Contraception · 201337 citationsRCR 1.9
- Intrauterine lidocaine infusion for pain management in first-trimester abortions.Obstet Gynecol · 200435 citationsRCR 1.6
- Opioid Analgesia for Medical Abortion: A Randomized Controlled Trial.Obstet Gynecol · 201932 citationsRCR 2.2
- Pain experienced using two different methods of endometrial biopsy: a randomized controlled trial.Obstet Gynecol · 201130 citationsRCR 1.0